Apical hypertrophic cardiomyopathy: A case series at a Brazilian referral center with a maximal follow-up of 15 years

Author(s):  
A.V.F. Chaves ◽  
L. Soares Bezerra ◽  
M.A. Oliveira Santos-Veloso ◽  
E.B. Calado ◽  
M. Markman ◽  
...  
2008 ◽  
Vol 30 (3) ◽  
pp. 343-346 ◽  
Author(s):  
Tomoyuki Miyamoto ◽  
Hitoshi Horigome ◽  
Satoru Kawano ◽  
Ryo Sumazaki

2019 ◽  
Vol 26 (6) ◽  
pp. 2125-2128 ◽  
Author(s):  
Takashi Norikane ◽  
Yuka Yamamoto ◽  
Yasukage Takami ◽  
Katsuya Mitamura ◽  
Ryosuke Tani ◽  
...  

Circulation ◽  
2007 ◽  
Vol 116 (suppl_16) ◽  
Author(s):  
Christine H Attenhofer Jost ◽  
Josepha Binder ◽  
Kyle W Klarich ◽  
Steve R Ommen ◽  
Heidi M Connolly ◽  
...  

Background. Apical hypertrophic cardiomyopathy (AHCM) has been considered a ``benign” form of HCM in Asian and non-Asian patients (pt). However, data on long-term outcome of pt with AHCM are limited. The purpose of this study was to determine the natural history of pt with AHCM followed at a tertiary referral center in North America. Methods. Between July 1976 and September 2006, 193 pt with the diagnosis of AHCM were seen at the Hypertrophic Cardiomyopathy Clinic. The last echocardiographic exam was reviewed in all pt. Follow-up data were obtained where possible (clinic visit). Results. Mean age at diagnosis 56±17 years, mean age at first presentation at our center was 58±17 years. Symptoms included chest pain in 69 pt (36 %), and exertional dyspnea ≥NYHA II in 97 pt (50 %). A family history of either HCM and/or sudden cardiac death was reported by 36 pt (19 %). Coronary artery disease was proven in 40 pt (21 %). Median follow up was 50 months (1–318) and obtained in 124 pt (64 %). The following events were reported at the last clinic visit: heart failure in =5 pt, syncope in =0 pt, ventricular tachycardia in =7 pt, ICD implantation in 22 pt, and stroke in 22 pt. Death from all causes occurred in 51 of 193 pt (26 %) at a mean age of 72 years (14–78). Kaplan-Meier survival analysis was used to examine survival from all causes of death since first presentation. Observed survival in patients with AHCM was significantly less than expected in an age- and gender matched Minnesota white population (p=0.009). The observed survival at 5, 10 and 15 years was 87 %, 82 %, and 57 % respectively, while the expected survival for these time points was 91 %, 81 %, and 72 %. Conclusions. AHCM in this predominantly North American patient population is associated with an increased mortality. Patients with AHCM have a high incidence of significant cardiovascular symptoms and ventricular arrhythmias. As the disease is less benign than previously suspected, careful longitudinal care by a cardiologist is warranted.


2016 ◽  
Vol 7 (1) ◽  
pp. 46-50 ◽  
Author(s):  
Karan Kapoor ◽  
Amal Chaudhry ◽  
Matthew C. Evans ◽  
Amish Sura

2013 ◽  
Vol 111 (12) ◽  
pp. 1784-1791 ◽  
Author(s):  
Kyle W. Klarich ◽  
Christine H. Attenhofer Jost ◽  
Josepha Binder ◽  
Heidi M. Connolly ◽  
Christopher G. Scott ◽  
...  

1990 ◽  
Vol 15 (1) ◽  
pp. 83-90 ◽  
Author(s):  
John G. Webb ◽  
Zion Sasson ◽  
Harry Rakowski ◽  
Peter Liu ◽  
E. Douglas Wigle

2019 ◽  
Vol 4 (2) ◽  
pp. 91-95
Author(s):  
Nicolas A. Yannuzzi ◽  
Karen Brown ◽  
Natalia F. Callaway ◽  
Nimesh A. Patel ◽  
Thomas A. Albini ◽  
...  

Purpose: This article reports the influence of timing on the clinical outcomes in primary extramacular rhegmatogenous retinal detachment (RRD) at a tertiary referral center. Methods: A retrospective case series was conducted of all patients presenting between January 1, 2014 and December 31, 2016, with primary extramacular RRD. Retinal detachments with grade C proliferative vitreoretinopathy, combined tractional and RRD, eyes with inflammatory disease, and prior retinal surgery were excluded. The main outcome measures were single-operation anatomic success (SOAS), final anatomic success, and best-corrected visual acuity (BCVA). Results: There were 202 eyes of 198 patients with an average of 22 months’ follow-up (range, 6-47 months). Eyes were operated on an average of 1.1 days after initial presentation. At last clinical examination, SOAS had been achieved in 174 (86%) eyes, final anatomic success in 200 (99%) eyes, and average postoperative logarithm of the minimum angle of resolution (logMAR) BCVA was 0.18 (Snellen equivalent, 20/30; SD, 0.36). In those treated the day of presentation, average postoperative logMAR BCVA was 0.18 (Snellen, 20/31) in comparison to 0.18 (Snellen, 20/30) in those treated the day after presentation and 0.14 (Snellen, 20/28) in those treated after 2 days or more ( P = .92). Conclusions: Regarding timing of surgery, SOAS and BCVA outcomes in primary extramacular RRDs were favorable with an urgent and semiurgent approach to repair. There was no difference in visual and anatomic outcomes between patients who were operated on the day of presentation and those treated a short time later when clinical decisions were made by the treating surgeon on a case-by-case basis.


Sign in / Sign up

Export Citation Format

Share Document